reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Yubo International Biotech Ltd

YBGJ · OTC

1 reporting failure in the last 12 months

Companies at this level ended the following year delisted, bankrupt, restated or silent 9.2% of the time, against 4.0% for companies with a clean record.

—public float
2026-01-16most recent failure

Score over time

01234202220232024202520262022-01-01 · score 32021-08-16 filed late (10-Q) · accounts not ready2021-05-14 filed late (10-Q) · accounts not ready2021-01-15 filed late (10-Q) · auditor2022-04-01 · score 32022-03-24 filed late (10-K) · accounts not ready2021-08-16 filed late (10-Q) · accounts not ready2021-05-14 filed late (10-Q) · accounts not ready2022-07-01 · score 22022-03-24 filed late (10-K) · accounts not ready2021-08-16 filed late (10-Q) · accounts not ready2022-10-01 · score 12022-03-24 filed late (10-K) · accounts not ready2023-01-01 · score 22022-11-14 filed late (10-Q) · accounts not ready2022-03-24 filed late (10-K) · accounts not ready2023-04-01 · score 22023-03-28 filed late (10-K) · accounts not ready2022-11-14 filed late (10-Q) · accounts not ready2023-07-01 · score 22023-03-28 filed late (10-K) · accounts not ready2022-11-14 filed late (10-Q) · accounts not ready2023-10-01 · score 22023-03-28 filed late (10-K) · accounts not ready2022-11-14 filed late (10-Q) · accounts not ready2024-01-01 · score 22023-11-13 filed late (10-Q) · accounts not ready2023-03-28 filed late (10-K) · accounts not ready2024-04-01 · score 22024-03-28 filed late (10-K) · accounts not ready2023-11-13 filed late (10-Q) · accounts not ready2024-07-01 · score 32024-05-13 filed late (10-Q) · accounts not ready2024-03-28 filed late (10-K) · accounts not ready2023-11-13 filed late (10-Q) · accounts not ready2024-10-01 · score 42024-08-13 filed late (10-Q) · accounts not ready2024-05-13 filed late (10-Q) · accounts not ready2024-03-28 filed late (10-K) · accounts not ready2023-11-13 filed late (10-Q) · accounts not ready2025-01-01 · score 32024-08-13 filed late (10-Q) · accounts not ready2024-05-13 filed late (10-Q) · accounts not ready2024-03-28 filed late (10-K) · accounts not ready2025-04-01 · score 32025-01-06 auditor change2024-08-13 filed late (10-Q) · accounts not ready2024-05-13 filed late (10-Q) · accounts not ready2025-07-01 · score 22025-01-06 auditor change2024-08-13 filed late (10-Q) · accounts not ready2025-10-01 · score 12025-01-06 auditor change2026-01-01 · score 12025-01-06 auditor change2026-04-01 · score 12026-01-16 auditor change2026-07-01 · score 12026-01-16 auditor change2026-10-01 · score 12026-01-16 auditor change

Hover or tap a dot to see the filings behind that score.

Why they said they were late

Yubo International Biotech Limited (the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the three and six months ended June 30, 2024 (the “Form 10-Q”) within the prescribed time period without unreasonable effort and expense. The Company is still in process of compiling certain required information to complete the review of its consolidated financial statements. As a result, the Company requires additional time to prepare and file the Form 10-Q. The Company expects to file the Form 10-Q on or before the fifth calendar day extension provided by Rule 12b-25

NT 10-Q, filed 2024-08-13 · accounts not ready

What it filed

2026-01-16auditor changed or resigned SEC →

2025-01-06auditor changed or resigned SEC →

2024-08-13filed late (10-Q)accounts not ready SEC →

Yubo International Biotech Limited (the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the three and six months ended June 30, 2024 (the “Form 10-Q”) within the prescribed time period without unreasonable effort and expense. The Company is still in process of compiling certain required information to complete the review of its consolidated financial statements. As a result, the Company requires additional time to prepare and file the Form 10-Q. The Company expects to file the Form 10-Q on or before the fifth calendar day extension provided by Rule 12b-25

2024-05-13filed late (10-Q)accounts not ready SEC →

Yubo International Biotech Limited (the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the three months ended March 31, 2024 (the “Form 10-Q”) within the prescribed time period without unreasonable effort and expense. The Company is still in the process of compiling certain required information to complete the review of its consolidated financial statements. As a result, the Company requires additional time to prepare and file the Form 10-Q. The Company expects to file the Form 10-Q on or before the fifth calendar day extension provided by Rule 12b-25

2024-03-28filed late (10-K)accounts not ready SEC →

Yubo International Biotech Limited (the “Company”) has determined that it is unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”) within the prescribed time period without unreasonable effort and expense. The Company is still in process of compiling certain required information to complete the audit of its financial statements for fiscal year 2023. As a result, the Company requires additional time to prepare and file the Form 10-K. The Company expects to file the Form 10-K on or before the fifteenth calendar day extension provided by Rule 12b-25

2023-11-13filed late (10-Q)accounts not ready SEC →

Yubo International Biotech Limited (the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2023 (the “Form 10-Q”) within the prescribed time period without unreasonable effort and expense. The Company is still in process of compiling certain required information to complete the review of its consolidated financial statements. As a result, the Company requires additional time to prepare and file the Form 10-Q. The Company expects to file the Form 10-Q on or before the fifth calendar day extension provided by Rule 12b-25

2023-03-28filed late (10-K)accounts not ready SEC →

Yubo International Biotech Limited (the “Company”) has determined that it is unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”) within the prescribed time period without unreasonable effort and expense. The Company is still in process of compiling certain required information to complete the review of its consolidated financial statements. As a result, the Company requires additional time to prepare and file the Form 10-K. The Company expects to file the Form 10-K on or before the fifteenth calendar day extension provided by Rule 12b-25

2022-11-14filed late (10-Q)accounts not ready SEC →

Yubo International Biotech Limited (the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 (the “Form 10-Q”) within the prescribed time period without unreasonable effort and expense. The Company is still in process of compiling certain required information to complete the Form 10-Q. As a result, the Company requires additional time to prepare and review its consolidated financial statements and other disclosures in the Form 10-Q. The Company expects to file the Form 10-Q on or before the fifth calendar day extension provided by Rule 12b-25

2022-03-24filed late (10-K)accounts not ready SEC →

Yubo International Biotech Limited (the “Company”) has determined that it is unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “Form 10-K”) within the prescribed time period without unreasonable effort and expense. The Company is still in process of compiling certain required information to complete the Form 10-K. As a result, the Company requires additional time to prepare and review its consolidated financial statements and other disclosures in the Form 10-K. The Company expects to file the Form 10-K on or before the fifteenth calendar day extension provided by Rule 12b-25

2021-08-16filed late (10-Q)accounts not ready SEC →

Yubo International Biotech Limited (the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the “Form 10-Q”) within the prescribed time period without unreasonable effort and expense. The Company is still in process of compiling certain required information to complete the Form 10-Q. As a result, the Company requires additional time to prepare and review its consolidated financial statements and other disclosures in the Form 10-Q. The Company expects to file the Form 10-Q on or before the fifth calendar day extension provided by Rule 12b-25

2021-05-14filed late (10-Q)accounts not ready SEC →

Yubo International Biotech Limited (the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the three-month period ended March 31, 2021 (the “Form 10-Q”) within the prescribed time period without unreasonable effort and expense. The Company is still in process of compiling certain required information to complete the Form 10-Q. As a result, the Company requires additional time to prepare and review its consolidated financial statements and other disclosures in the Form 10-Q. The Company expects to file the Form 10-Q on or before the fifth calendar day extension provided by Rule 12b-25

2021-01-15filed late (10-Q)auditor SEC →

Additional time is needed to complete the preparation and review of the Registrant’s quarterly report for the three-month period ended November 30, 2020. The Registrant’s independent auditors will not be able to complete their review of the financial statements prior to January 31, 2021

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com